loader from loading.io

The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy - Part 4

Neurology Minute

Release Date: 04/15/2025

Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 2 show art Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 2

Neurology Minute

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer explore the subcategories of Lewy body disease, focusing on the body-first subtype Show reference:  

info_outline
AAN’s President’s Award Recipient for 2025 - Part 2 show art AAN’s President’s Award Recipient for 2025 - Part 2

Neurology Minute

In the second installment of this two-part series, Dr. Stacey Clardy and Dr. Janis Miyasaki discuss how she got involved with the AAN.  Show reference:    

info_outline
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 1 show art Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 1

Neurology Minute

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer examine the dichotomy that existed before his team began this project. Show reference:  

info_outline
AAN’s President’s Award Recipient for 2025 - Part 1 show art AAN’s President’s Award Recipient for 2025 - Part 1

Neurology Minute

In the first installment of this two-part series, Dr. Stacey Clardy engages in a thought-provoking conversation with Dr. Janis Miyasaki, asking her to share two invaluable pieces of wisdom. Show reference:   

info_outline
Progressive Multiple Sclerosis show art Progressive Multiple Sclerosis

Neurology Minute

Dr. Jeff Lambe talks about progressive multiple sclerosis.  Show references:    

info_outline
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes show art Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes

Neurology Minute

Dr. Justin Abbatemarco discuss autoimmune encephalitis with a focus on outcomes.  Show reference:   

info_outline
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2 show art Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2

Neurology Minute

In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.

info_outline
Spontaneous Intracranial Hypotension Updates show art Spontaneous Intracranial Hypotension Updates

Neurology Minute

Dr. Jessica Ailani and Dr. Kathleen Digre discuss the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.

info_outline
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 1 show art Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 1

Neurology Minute

In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic. 

info_outline
Neuroimmunology Update 2025: MOGAD Treatments show art Neuroimmunology Update 2025: MOGAD Treatments

Neurology Minute

Dr. Justin Abbatemarco discusses updates around MOGAD treatments.  Show references:    

info_outline
 
More Episodes

In the final episode of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss the abstract she presented at the AAN Annual Meeting and details on the upcoming gene therapy trial. 

Show reference:

https://www.neurology.org/doi/10.1212/WNL.0000000000208987